Camurus AB (publ) (STO:CAMX)
649.00
-6.50 (-0.99%)
At close: Oct 23, 2025
Camurus AB Employees
Camurus AB had 256 employees as of December 31, 2024. The number of employees increased by 43 or 20.19% compared to the previous year.
Employees
256
Change (1Y)
43
Growth (1Y)
20.19%
Revenue / Employee
8.49M SEK
Profits / Employee
2.69M SEK
Market Cap
38.69B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 256 | 43 | 20.19% |
| Dec 31, 2023 | 213 | 37 | 21.02% |
| Dec 31, 2022 | 176 | 28 | 18.92% |
| Dec 31, 2021 | 148 | 14 | 10.45% |
| Dec 31, 2020 | 134 | 14 | 11.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Medicover AB | 47,256 |
| Getinge AB | 11,791 |
| Nolato AB | 5,837 |
| Elekta AB | 4,556 |
| Asker Healthcare Group AB | 4,030 |
| AddLife AB | 2,181 |
| Swedish Orphan Biovitrum AB | 1,806 |
| Sectra AB | 1,296 |
Camurus AB News
- 4 months ago - Camurus' POSITANO study shows treatment effects with CAM2029 in polycystic liver disease patients - PRNewsWire
- 5 months ago - Camurus and Lilly enter collaboration and license agreement for long-acting FluidCrystal® incretins - PRNewsWire
- 6 months ago - CHMP recommends approval of Oczyesa® for treatment of acromegaly in the EU - PRNewsWire
- 1 year ago - Camurus AB (CAMRF) Q3 2024 Earnings Call Highlights: Record Profit and Revenue Growth Amid ... - GuruFocus
- 1 year ago - Q3 2024 Camurus AB Earnings Call Transcript - GuruFocus
- 1 year ago - US FDA declines to approve Camurus' rare hormone disorder drug - Reuters
- 1 year ago - New publication shows effectiveness data for weekly and monthly buprenorphine injections in treating opioid dependence in individuals using fentanyl - PRNewsWire